Susquehanna Fundamental Investments LLC Acquires New Stake in National Health Investors, Inc. $NHI

Susquehanna Fundamental Investments LLC bought a new position in shares of National Health Investors, Inc. (NYSE:NHI) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 7,485 shares of the real estate investment trust’s stock, valued at approximately $571,000.

Other large investors have also modified their holdings of the company. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC boosted its position in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in National Health Investors during the fourth quarter worth about $33,000. Allworth Financial LP purchased a new stake in National Health Investors during the 2nd quarter valued at about $42,000. Finally, Advisory Services Network LLC purchased a new stake in National Health Investors during the 3rd quarter valued at about $65,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft decreased their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. BMO Capital Markets cut their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday, June 15th. Wells Fargo & Company reduced their price objective on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Finally, Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, National Health Investors has a consensus rating of “Moderate Buy” and a consensus price target of $83.57.

Insider Buying and Selling

In other National Health Investors news, CEO D. Eric Mendelsohn acquired 1,500 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 2.70% of the company’s stock.

National Health Investors Price Performance

National Health Investors stock opened at $71.70 on Thursday. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The stock has a market cap of $3.52 billion, a P/E ratio of 20.72, a PEG ratio of 3.84 and a beta of 0.52. The company has a 50-day moving average price of $75.60 and a 200 day moving average price of $78.38. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last issued its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. National Health Investors’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period last year, the firm earned $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Sell-side analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.1%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s payout ratio is presently 106.36%.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.